Episode 3: How a Robust Canadian Life Sciences Strategy Will Drive Health and Wealth
A robust life sciences strategy will generate national prosperity and support more resilient healthcare systems across Canada.
Hosted by the Resilient Healthcare Coalition (RHC), this dynamic virtual roundtable spotlighted the lifesciencescan campaign (www.lifesciencescan.ca) and its recent call for a National Life Sciences Strategy for Canada. It highlighted some of the specific steps Canadian policymakers and their sector partners should immediately take to demonstrate collaborative leadership. It also emphasized the importance of improving patient outcomes by accelerating and expanding access to health technologies, and by optimizing the collection, integration and analysis of health care data.
Opening remarks were given by The Honourable Perrin Beatty, PC, OC, President and Chief Executive Officer of the 200,000-member Canadian Chamber of Commerce.
This event featured a panelist roundtable. RHC Co-Chair Dr. Jason Field was joined by:
Nicole DeKort, Vice President Ontario & Marketing, Medtech Canada
Rory Francis, Chief Executive Officer, PEI BioAlliance
Wendy Hurlburt, President and CEO, Life Sciences BC
Anie Perrault, Executive Director, BioQuebec
For those who want to listen, find the podcast below or on SoundCloud.
For those who want to read, find the event summary here.
Time Stamps
Opening Remarks by Perrin Beatty: 02:20
Question 1: 10:50
“Can you reflect on the trajectory of your respective life sciences communities, think about what you’ve seen over the last 18 months, and comment on what you are most excited about and most hopeful for in the months to come?”
Question 2: 36:13
“What kind of partnership and collaboration are you all looking for between federal and provincial governments, and what do you see as the central role your organizations can play in fostering and furthering collaboration even more broadly?”
Question 3: 52:32
“How are we going to assess our progress? What are you looking for to see if we are tracking in the right direction? What are the milestones, indicators or developments that you will ideally want to point to?”
Closing Remarks: 57:48
*This event recording has been lightly edited to improve clarity and flow.